VISUfarma VISUfly

VISUfly is a specialized dietary supplement designed to support eye health, specifically targeting the management of vitreous floaters (myodesopsia). It contains a complex of proteolytic fruit enzymes like bromelain, ficin, and papain, along with Peptan® collagen, L-glutathione, and Vitamin C to protect ocular cells from oxidative stress.

The brand was established by VISUfarma, a pharmaceutical company founded in Italy in 2016 through the merger of VISUfarma SpA and the European commercial activities of Nicox SA. While the brand has deep Italian roots and is headquartered in Rome, it has grown into a pan-European entity with a significant presence across the UK, Spain, Germany, and France.

In late 2025, VISUfarma was acquired by Lupin Limited, a major global pharmaceutical company based in India. This acquisition by Lupin's subsidiary, Nanomi B.V., was part of a strategic move to expand their European footprint in the specialty ophthalmology market. Consequently, the ultimate ownership of the brand now resides with Lupin Limited, although local distribution and operations continue through its established European subsidiaries.